Novavax
The European Medicines Agency on Thursday identified severe allergic reactions as potential side effects of Novavax Inc's (NVAX.O) COVID-19 vaccine. U.S. regulators authorized the vaccine on Wednesday, and its product label in the Un..
Novavax Inc said on Tuesday its COVID-19 vaccine has got emergency-use authorization from the Drugs Controller General of India for children aged 12 to 17 years. The authorization is a global first for the age group for the vaccine, which is manuf..
The UK has approved a fifth Covid-19 vaccine, developed by US company Novavax, which offers up to 89% protection against Covid illness. The Medicines and Healthcare products Regulatory Agency has said it is safe as a first and second dose in adult..
Novavax Inc (NVAX.O) said on Friday it had started working on a version of its COVID-19 vaccine to target the variant detected in South Africa and would have the shot ready for testing and manufacturing in the next few weeks. The company..
Novavax Inc said on Friday (Nov 26) it had started working on a version of its COVID-19 vaccine to target the variant detected in South Africa and would have the shot ready for testing and manufacturing in the next few weeks. The company's COV..
REUTERS Vaccine developer Novavax Inc (NVAX.O) said on Wednesday it has initiated an early-stage study to test its combined flu and COVID-19 vaccine. The trial, to be conducted i...
.jpg)
.jpg)
.jpg)
.png)
.jpg)
